DUBLIN, Ireland--(BUSINESS WIRE)--ICON (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2007. Net revenues for the quarter were $166.9 million, representing a 38.3% increase over net revenues of $120.7 million for the same quarter last year. Income from operations, after taking non-cash stock compensation charge of $1.4 million, was $18.7 million or 11.2% of revenue, compared to $12.6 million or 10.4% for the same quarter last year. Net income was $14.5 million or 49 cents per share on a diluted basis, compared with $10.1 million or 35 cents per share last year.
